About Clinical Laboratory Partners
Clinical Laboratory Partners is a provider of clinical diagnostic testing services for healthcare providers, both hospitals and private practices, effectively competing in local markets against a range of national and other local clinical diagnostic laboratories.
Latest Clinical Laboratory Partners News
Feb 29, 2016
MADISON, N.J. and HARTFORD, Conn., Feb. 29, 2016 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX ), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of the outreach laboratory service business of Clinical Laboratory Partners (CLP), a wholly-owned subsidiary of Hartford HealthCare (HHC). HHC is an integrated health care system with five hospitals in Connecticut. Financial terms were not disclosed. With the acquisition, people and providers in Connecticut will have broader access to quality, affordable and convenient laboratory services, with a broader network of patient service centers and three rapid-response clinical laboratories in the state. Physicians in Connecticut will also be able to order testing and consult with Quest Diagnostics' medical experts at Quest's full-service clinical laboratory in Marlborough, Mass. This lab provides state-of-the-art testing services, such as next-generation sequencing and bioinformatics, to aid the detection of cancer, dementia and other diseases. HHC's hospital-based laboratories and the inpatient and outpatient services they provide are not included in the transaction and will remain part of the HHC system. Professional consultative pathology services performed by Hartford Pathology Associates are also not part of the acquisition. This is the fifth acquisition of a laboratory outreach service business from a hospital system by Quest Diagnostics since 2012, when the company introduced its five-point strategy, which includes restoring growth and driving disciplined capital deployment through strategically-aligned, accretive acquisitions. The company has also formed several agreements with hospitals to provide professional laboratory services, such as lab management outsourcing. Quest's scale and expertise enable it to produce highly innovative test services cost-effectively, with fees that are often far lower than those of other providers for comparable services, according to independent research. About Quest Diagnostics Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 45,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. www.QuestDiagnostics.com . Quest Diagnostics Contacts: Wendy Bost, Quest Diagnostics (Media): 973-520-2800 Dan Haemmerle, Quest Diagnostics (Investors): 973-520-2900 Hartford HealthCare Contact:
Clinical Laboratory Partners Frequently Asked Questions (FAQ)
Where is Clinical Laboratory Partners's headquarters?
Clinical Laboratory Partners's headquarters is located at 129 Patricia M. Genova Dr., Newington.
What is Clinical Laboratory Partners's latest funding round?
Clinical Laboratory Partners's latest funding round is Other Investors.
Who are the investors of Clinical Laboratory Partners?
Investors of Clinical Laboratory Partners include Oxford Bioscience Partners.
Who are Clinical Laboratory Partners's competitors?
Competitors of Clinical Laboratory Partners include Affidea, iMMCO Diagnostics, Insight Imaging, CyVek, LipoScience and 7 more.
Compare Clinical Laboratory Partners to Competitors
GDXI is a provider of telemedical EKG testing and information services, data management and diagnostic services in the home healthcare and other non-hospital environments.
Affidea is a medical service provider. It specializes in diagnostics investigations, clinical laboratories, and cancer treatment services. The company was formerly known as Euromedic. It was founded in 1991 and is based in The Hague, Netherlands. In April 2022, Groupe Bruxelles Lambert acquired a majority stake in Affidea. The terms of the transaction were not disclosed.
Lifelinelab s.r.l. started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. First step has been to secure raw materials, and equipment for R&D and Manufacturing of products and services in the field of Human in Vitro Diagnostics. nnnnnFirst diagnostic reagents were manufactured, in this site, over 40 years ago, through the bravery and the enterprising spirit of Prof. Balducci ex Managing Director of Virology Laboratory of "Istituto Superiore di Sanitu00e0". First products were based on tissue colture technology included a line of complement fixation antigens. Since then, the company developed methods and products, covering almost all the fields of Human in Vitro Diagnostics, from Clinical Chemistry to Immunochemistry. The mostly developed sector has been that of Infectious Diseases with particular regard to Viral pathologies. Most products have been developed using biological raw materials derived from in house, in vivo or in vitro, productions. Nowadays the company aims to face and develop markets with consolidate and emerging technologies such as Microarrays using a chemistry patented and designed to covalently bind either Protein or Nucleic acids which aims to allow the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.
iMMCO Diagnostics specializes in autoimmune diagnostics within the healthcare sector. The company provides a comprehensive range of diagnostic solutions including IFAs, EIAs, Line Immunoassays, and Western Blots for various autoimmune disorders. iMMCO Diagnostics also offers reference laboratory services for the diagnosis and management of autoimmune diseases. It is based in Buffalo, New York.
Beacon Analytical Systems is a biotechnology company specializing in the development and manufacturing of immunoassay test kits. These kits are designed to detect toxins, contaminants, and other chemical compounds in various sectors such as environmental monitoring, agriculture, and food safety. The company primarily serves industries that require rigorous testing for safety and quality assurance. It is based in Portland, Maine.
Insight Imaging is a healthcare company that specializes in providing mobile diagnostic ultrasound services. The company offers on-site ultrasound services to medical practices, utilizing advanced equipment to conduct diagnostic tests in the comfort of the patient's regular healthcare setting. The primary customers of Insight Imaging are medical practices across various specialties. It is based in Charlotte, North Carolina.